SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-050806
Filing Date
2023-02-27
Accepted
2023-02-27 16:25:04
Documents
12
Period of Report
2022-12-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d465534d8ka.htm   iXBRL 8-K/A 22428
  Complete submission text file 0001193125-23-050806.txt   144905

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20221228.xsd EX-101.SCH 2839
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20221228_lab.xml EX-101.LAB 17943
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20221228_pre.xml EX-101.PRE 11239
6 EXTRACTED XBRL INSTANCE DOCUMENT d465534d8ka_htm.xml XML 4079
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39695 | Film No.: 23675297
SIC: 2834 Pharmaceutical Preparations